Turn Therapeutics Inc.
TTRX
$3.53
$0.030.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.11M | 3.19M | 872.60K | -- | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 188.60K | 204.00K | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 3.29M | 3.39M | -- | -- | |
|
|
|||||
| Total Current Assets | 3.29M | 3.39M | -- | -- | |
| Net Property, Plant & Equipment | 89.40K | 100.00K | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | 904.90K | 828.80K | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 8.60K | 8.60K | -- | -- | |
| Total Assets | 4.30M | 4.33M | -- | -- | |
|
|
|||||
| Total Accounts Payable | 2.26M | 1.02M | -- | -- | |
| Total Accrued Expenses | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 44.80K | 43.40K | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 2.31M | 1.06M | -- | -- | |
|
|
|||||
| Total Current Liabilities | 2.31M | 1.06M | -- | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 46.30K | 58.00K | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 1.44M | 1.44M | -- | -- | |
| Total Liabilities | 3.79M | 2.56M | -- | -- | |
|
|
|||||
| Common Stock & APIC | 23.23M | 23.19M | -- | -- | |
| Retained Earnings | -22.67M | -20.77M | -- | -- | |
| Treasury Stock & Other | -52.70K | -647.30K | -- | -- | |
| Total Common Equity | 504.00K | 1.77M | -177.40K | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 504.00K | 1.77M | -177.40K | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 504.00K | 1.77M | -177.40K | -- | |
|
|
|||||